Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.Muscle & Nerve|July 16, 2026
Patient Communication Outside of Visits: Implications for Remote Monitoring and Digital Care Models in Myasthenia GravisMaike Stein, Lea Gerischer, Yvonne J M Campman, et al.Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.Frontiers in Neurology|January 1, 2024
The burden of myasthenia gravis - highlighting the impact on family planning and the role of social supportMaike Stein, Ulrike Grittner, Regina Stegherr, et al.Archives of Gynecology and Obstetrics|March 16, 2024
Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in GermanyJakob Draxler, Andreas Meisel, Frauke Stascheit, et al.Journal of Autoimmunity|September 10, 2025
Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy-A pilot studyFrauke Stascheit, Daniel Schulze, Sophie Lehnerer, et al.Annals of Clinical and Translational Neurology|December 21, 2025
Remote Monitoring in Myasthenia Gravis: Exploring Symptom VariabilityMaike Stein, Maximilian Mönch, Meret Herdick, et al.Healthcare (Basel, Switzerland)|January 11, 2024
German Porphyria Registry (PoReGer)-Background and SetupLea Gerischer, Mona Mainert, Nils Wohmann, et al.Frontiers in Neurology|March 12, 2024
Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters - a pilot studyAnne Mehnert, Sivan Bershan, Jil Kollmus-Heege, et al.Annals of Clinical and Translational Neurology|November 20, 2025
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and EculizumabLea Gerischer, Frauke Stascheit, Maximilian Mönch, et al.Pageof 3